NEVE ILAN, Israel, Oct. 10, 2023 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that it is postponing the previously announced Investor Day scheduled for Tuesday, Oct. 17, 2023, at the Nasdaq in New York City. “It is […]
Other News
Philips and World Stroke Organization partner to improve access to high-quality stroke care
October 10, 2023 Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge Philips’ leadership in the rapid end-to-end treatment of stroke helping to improve patient outcomes and increase the efficiency of treatment Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a […]
SS Innovations Receives Regulatory Approvals from the Guatemala Ministry of Health
The Mantra Surgical Robotic System has been given the approval to be used for clinical use in Guatemala, marking the Company’s first regulatory approval in Central America FORT LAUDERDALE, FL, Oct. 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), […]
Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences
GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—today announced FDA clearance of updated software. Built on a robust AI foundation, the latest software brings image quality enhancements to the […]
CorWave Announces the Grand Opening of Its Manufacturing Facility on the Banks of the Seine, next to Paris
CLICHY, France–(BUSINESS WIRE)–CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th. The company occupies over 2,400m² of production, laboratory, and office space, bringing together […]
WhiteSwell Announces Successful Treatment of Acute Decompensated Heart Failure Patients in its Early Feasibility DELTA-HF Study
GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in […]
Nanoflex Robotics Secures CHF 2.9M from Swiss Innovation Agency
ZURICH, Switzerland, Oct. 09, 2023 (GLOBE NEWSWIRE) — Nanoflex Robotics AG, a remote robotic surgical company based in Switzerland, announced it has received a second grant from Innosuisse, Switzerland’s Innovation Agency this year. The receipt of the second grant brings Nanoflex Robotics’ total non-dilutive grant funding received from Innosuisse this […]
Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting
SOUTH SAN FRANCISCO, Calif. and CLEVELAND, Oct. 09, 2023 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today released new data for TN-301 at the 2023 Heart […]
Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
NAPERVILLE, Ill., Oct. 9, 2023 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational Device Exemption (IDE) approval from the FDA for a subsequent multicenter study, PROACTIVE-HF 2, which will evaluate the company’s Cordella Sensor for pulmonary artery […]
Late-Breaking Data Confirms Safety of Axon Therapies’ Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy
SANTA CLARA, Calif., Oct. 8, 2023 /PRNewswire/ — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced 6-month results of the REBALANCE-HF randomized, blinded feasibility trial of the Splanchnic Ablation for Volume Management (SAVM) procedure for heart failure with preserved ejection fraction (HFpEF). The main objectives of the […]
Recent
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Popular
- No commented posts yet